Library
PubMed
research article
Professional

Recurrent Coronary Restenosis in Takayasu Arteritis: A Stent-Sparing Strategy.

Source: PubMed, NCBI / U.S. National Library of Medicine

JACC. Case reportsRayyan Abdallah, Mestarihi Aseed, Shah Khanjan, et al.Published 6/12/2026Last synced 6/14/2026Status: syncedPMID: 42283679DOI: 10.1016/j.jaccas.2026.108817

Coronary involvement in Takayasu arteritis is uncommon but associated with high rates of in-stent restenosis and challenging revascularization. A 22-year-old woman with Takayasu arteritis and congenital antithrombin III deficiency presented with non-ST-segment elevation myocardial infarction due to severe ostial right coronary artery in-stent restenosis after multiple prior percutaneous interventions. Intravascular ultrasound confirmed significant neointimal hyperplasia. A stent-sparing strategy using excimer laser coronary atherectomy, cutting balloon angioplasty, and paclitaxel drug-coated balloon under intravascular ultrasound guidance was performed with bivalirudin anticoagulation. Final angiography demonstrated TIMI 3 flow with significant luminal gain. Recurrent restenosis in Takayasu arteritis represents a major therapeutic challenge. This case highlights the role of multimodal, stent-avoidant strategies and individualized anticoagulation in complex inflammatory vasculopathy with concomitant thrombophilia. Recurrent in-stent restenosis in Takayasu arteritis reflects ongoing vascular inflammation and requires strategies beyond repeat stenting. A stent-sparing, intravascular imaging-guided approach using laser atherectomy and drug-coated balloon can effectively treat refractory restenosis while minimizing additional stent burden.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.